Covid-19 vaccine: India looking at $11 billion market opportunity

​​"On an aggregate level (i.e., domestic plus export), CARE Ratings expects supply opportunity of at least around USD 10-11 billion during the next three years for the Indian vaccine manufacturers," the report said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2UmHmsi
via IFTTT